BioMarin Pharmaceutical, Inc. (BMRN)

58.01 -0.12 (-0.21%) USD  |  NASDAQ  |  Feb 09, 15:13
More

BioMarin Pharmaceutical Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
Gilead Sciences, Inc. Upgrade
AbbVie, Inc. Upgrade
Amgen, Inc. Upgrade